首页> 美国卫生研究院文献>other >Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy

【2h】

Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy

机译：纳米粒子介导的化学治疗剂与siRNA共同递送以联合治疗癌症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

IntroductionCancer is the leading cause of death worldwide. Current cancer treatments in the clinic mainly include chemotherapy, radiotherapy and surgery, with chemotherapy being the most common.

机译：简介癌症是全球主要的死亡原因。临床上当前的癌症治疗主要包括化学疗法，放射疗法和手术，化学疗法是最常见的。

著录项

期刊名称 other
作者
Bo Xiao; Lijun Ma; Didier Merlin;
展开▼
作者单位

展开▼
年(卷),期 -1(14),1
年度 -1
页码 65–73
总页数 17
原文格式 PDF
正文语种
中图分类
关键词
co-delivery chemical drug siRNA nanoparticle combination therapy cancer;

机译：共交付;化学药物;siRNA;纳米颗粒;联合疗法;癌症;

相似文献

外文文献
中文文献
专利

1. Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy [J] . Xiao Bo, Ma Lijun, Merlin Didier Expert opinion on drug delivery . 2017,第1a6期

机译：纳米粒子介导的化学治疗剂和siRNA的共递送组合癌症治疗
2. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances [J] . Nishant S. Gandhi, Rakesh K. Tekade, Mahavir B. Chougule Journal of Controlled Release: Official Journal of the Controlled Release Society . 2014,第Null期

机译：纳米载体介导的siRNA / miRNA与化学治疗剂联合用于癌症治疗的进展：当前的进展和进展
3. Improved Cancer Immunochemotherapy via Optimal Co-delivery of Chemotherapeutic and Immunomodulatory Agents [J] . Chen Yichao, Sun Jingjing, Huang Yixian, Molecular pharmaceutics . 2018,第11期

机译：通过最佳共同递送化学治疗剂和免疫调节剂改善癌症免疫疗法
4. Useful Combination Therapy of Anti-angiogenic Agent with Chemotherapeutic Agents or RadionuclideTherapy for Cancer Treatment [C] . Sun-Ju Choi, So-Young Lee, Young-Don Hong Controlled Release Society Annual Meeting and Exposition . 2007

机译：抗血管生成剂与化学治疗剂或放射性核素的有效组合疗法可用于癌症治疗
5. Poly(Amido-Amine) Dendrimers-Based Nanomedicine for Combination Therapy with siRna and Chemotherapeutics to Overcome Multidrug Resistance in Cancer [D] . Pan, Jiayi. 2020

机译：基于Dendrimers的纳米医疗，用于组合治疗的聚（氨基胺）的纳米疗程，以克服癌症的多药耐药性
6. Nanocarrier mediated Delivery of siRNA/miRNA in Combination with Chemotherapeutic Agents for Cancer Therapy: Current Progress and Advances [O] . Nishant S. Gandhi, Rakesh K. Tekade, Mahavir B. Chougule -1

机译：纳米载体介导的siRNA / miRNA与化疗药物联合用于癌症治疗的递送：当前的进展和进展
7. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances [O] . Nishant S. Gandhi, Rakesh K. Tekade, Mahavir B. Chougule 2014

机译：NanoCarrier介导SiRNA / miRNA的递送与化学治疗剂组合用于癌症治疗：当前的进展和进步
8. Interaction Between Chemotherapeutic Agents and Biological Processes in Isolated Mammalian Cells. Coordinated Programme on Improvement in Radiotherapy of Cancer Using Modifiers of Radiosensitivity of Cells. Final Report for the Pe [R] . Djordjevic, O. 1982

机译：分离的哺乳动物细胞中化学治疗剂与生物过程的相互作用。利用细胞放射敏感性改良剂改善癌症放射治疗的协调计划。 pe的最终报告

Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy

摘要

著录项

相似文献

相关主题

期刊订阅